End-of-day summary:
The share market began the week with a modest retreat as CSL's failed drug trial and declines in mining stocks outweighed gains for most of the banks.
The ASX 200 reversed 30 points or 0.39% to its first loss in four sessions. Index heavyweight CSL accounted for much of the weakness, falling 4.84% after a promising heart-attack drug candidate failed at trial. Other drags included Woodside -2.17%, South32 -1.59% and Macquarie Group -1.44%.
A big week of earnings got off to a positive start with gains for JB Hi-Fi +7.13%, Beach Energy +3.32%, Aurizon +3.19% and Car Group +1.67% following trading updates this morning. The season continues tomorrow with updates from CSL, James Hardie and Seven West.
